REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,185,000 | -29.1% | 85,724 | 0.0% | 0.11% | -23.1% |
Q1 2022 | $1,672,000 | -57.3% | 85,724 | -39.0% | 0.15% | -57.0% |
Q3 2021 | $3,912,000 | +152.7% | 140,430 | +168.8% | 0.34% | +146.0% |
Q2 2021 | $1,548,000 | +6.0% | 52,235 | 0.0% | 0.14% | -19.2% |
Q1 2021 | $1,460,000 | +715.6% | 52,235 | +725.5% | 0.17% | +681.8% |
Q4 2020 | $179,000 | – | 6,328 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |